• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

amyotrophic lateral sclerosis

Pharma

Amylyx's ALS drug finally approved by FDA

The drug finally scored approval after not one, but two AdComms.
Zoey Becker Sep 29, 2022 5:00pm

BeiGene, Legend, Eisai-Biogen—Fierce Pharma Asia

Jul 8, 2022 10:29am

FDA will review Amylyx's ALS drug with a second expert panel

Jul 5, 2022 11:08am

Amylyx's first approval may carry a steep price, ICER argues

Jun 15, 2022 9:46am

Hengrui, Merck-Kelun, Dr. Reddy's and more—Fierce Pharma Asia

May 20, 2022 9:15am

Oral version of Mitsubishi's ALS drug Radicava gets FDA blessing

May 13, 2022 9:31am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy